Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. S.P.C. Lam

Publicaties

Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial

Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure

Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial

Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors

Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong

Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease

Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy

Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia

Association of Dapagliflozin vs Placebo with Individual Kansas City Cardiomyopathy Questionnaire Components in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial

Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF

Lees meer

Pers/media

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Wat is nieuw in de 2021 ESC HF richtlijn wat betreft patiënten met EF>40%?